Doaa Attia

1.1k total citations
21 papers, 156 citations indexed

About

Doaa Attia is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Ophthalmology. According to data from OpenAlex, Doaa Attia has authored 21 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Ophthalmology. Recurrent topics in Doaa Attia's work include Vasculitis and related conditions (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Ocular Diseases and Behçet’s Syndrome (4 papers). Doaa Attia is often cited by papers focused on Vasculitis and related conditions (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Ocular Diseases and Behçet’s Syndrome (4 papers). Doaa Attia collaborates with scholars based in Egypt, United States and Slovakia. Doaa Attia's co-authors include Sana Waheed, Michelle M. Estrella, Derek M. Fine, M Kokavec, Rasha A. Abdel Noor, Mohamed G. Atta, Radoslav Zamborský, Ľuboš Danišovič, Štefan Harsányi and Gregory M. Lucas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Doaa Attia

17 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doaa Attia Egypt 7 44 30 28 23 20 21 156
Rogin Subedi United States 7 48 1.1× 26 0.9× 12 0.4× 58 2.5× 12 0.6× 17 288
Léonard de Vinci Kanda Kupa Brazil 10 81 1.8× 31 1.0× 102 3.6× 71 3.1× 4 0.2× 32 228
Nesim Aladağ Türkiye 7 23 0.5× 21 0.7× 24 0.9× 43 1.9× 5 0.3× 21 175
Luis Fernando Pinto Colombia 6 60 1.4× 12 0.4× 7 0.3× 29 1.3× 7 0.3× 25 137
Karthik Viswanathan United Kingdom 9 22 0.5× 44 1.5× 20 0.7× 26 1.1× 13 0.7× 18 495
Irina Strâmbu Romania 8 15 0.3× 47 1.6× 30 1.1× 7 0.3× 6 0.3× 43 204
Kazuna Takata Japan 5 6 0.1× 37 1.2× 39 1.4× 20 0.9× 18 0.9× 7 279
Ariadna Anunciación-Llunell Spain 5 68 1.5× 18 0.6× 132 4.7× 60 2.6× 3 0.1× 11 279
Heleen A. Crommelin Netherlands 7 18 0.4× 29 1.0× 29 1.0× 16 0.7× 4 0.2× 11 309
Nadia Kerkeni Tunisia 8 31 0.7× 29 1.0× 11 0.4× 7 0.3× 9 0.5× 17 150

Countries citing papers authored by Doaa Attia

Since Specialization
Citations

This map shows the geographic impact of Doaa Attia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doaa Attia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doaa Attia more than expected).

Fields of papers citing papers by Doaa Attia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doaa Attia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doaa Attia. The network helps show where Doaa Attia may publish in the future.

Co-authorship network of co-authors of Doaa Attia

This figure shows the co-authorship network connecting the top 25 collaborators of Doaa Attia. A scholar is included among the top collaborators of Doaa Attia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doaa Attia. Doaa Attia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Attia, Doaa, et al.. (2024). Behçet’s Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort. Archives of Rheumatology. 39(4). 607–616. 1 indexed citations
3.
4.
Mokbel, Abir, et al.. (2023). Pregnancy outcomes among Egyptian women with systemic lupus erythematosus: A prospective cohort study. Lupus. 32(4). 521–530. 2 indexed citations
5.
6.
Attia, Doaa, et al.. (2021). Autoimmune Regulator Gene Polymorphisms in Egyptian Systemic Lupus Erythematosus Patients: Preliminary Results. International Journal of Rheumatology. 2021. 1–10. 2 indexed citations
7.
Attia, Doaa. (2021). Behçet's disease phenotypes and clinical outcomes: A cohort study in egyptian patients. Reumatología Clínica (English Edition). 17(9). 514–520. 1 indexed citations
8.
El‐Ashwah, Shaimaa, et al.. (2021). TERT Genotype Polymorphism: A Glance of Change Egyptian MDS Outcomes. Asian Pacific Journal of Cancer Prevention. 22(5). 1547–1555. 3 indexed citations
9.
Attia, Doaa, et al.. (2020). Sexual dysfunction in Egyptian females with systemic lupus erythematosus: a cross sectional study. Lupus. 29(9). 1085–1094. 6 indexed citations
10.
11.
Attia, Doaa. (2020). Behçet's disease phenotypes and clinical outcomes: A cohort study in egyptian patients. Reumatología Clínica. 17(9). 514–520. 5 indexed citations
12.
Attia, Doaa & Rasha A. Abdel Noor. (2020). Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study. SHILAP Revista de lepidopterología. 71(4). 218–225. 4 indexed citations
13.
Angelini, Dana E., et al.. (2020). Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin. Blood. 136(Supplement 1). 27–27. 6 indexed citations
14.
Attia, Doaa, et al.. (2020). Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis. Blood. 136(Supplement 1). 18–18. 2 indexed citations
15.
Attia, Doaa, et al.. (2019). Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome. Clinical Rheumatology. 38(6). 1675–1684. 8 indexed citations
16.
Attia, Doaa, et al.. (2019). Pregnancy outcome in women with active and inactive lupus nephritis: A prospective cohort study. Lupus. 28(7). 806–817. 16 indexed citations
17.
Negida, Ahmed, et al.. (2016). Caffeine; the Forgotten Potential for Parkinson's Disease. CNS & Neurological Disorders - Drug Targets. 16(6). 652–657. 21 indexed citations
18.
Waheed, Sana, Doaa Attia, Michelle M. Estrella, et al.. (2015). Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series. Clinical Kidney Journal. 8(4). 420–425. 35 indexed citations
19.
Attia, Doaa, Naima Carter‐Monroe, Gregory M. Lucas, et al.. (2014). The Clinical Characteristics and Pathological Patterns of Postinfectious Glomerulonephritis in HIV-Infected Patients. PLoS ONE. 9(10). e108398–e108398. 3 indexed citations
20.
Attia, Doaa. (2002). PLIF USING THE VARILIFT EXPANDABLE CAGES: AN EXPERIENCE REACHING 5 YEARS ABOUT STAND ALONE CAGES. 298–298. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rogin Subedi Breakdown of academic impact, for papers by Léonard de Vinci Kanda Kupa Breakdown of academic impact, for papers by Nesim Aladağ Breakdown of academic impact, for papers by Luis Fernando Pinto Breakdown of academic impact, for papers by Karthik Viswanathan Breakdown of academic impact, for papers by Irina Strâmbu Breakdown of academic impact, for papers by Kazuna Takata Breakdown of academic impact, for papers by Ariadna Anunciación-Llunell Breakdown of academic impact, for papers by Heleen A. Crommelin Breakdown of academic impact, for papers by Nadia Kerkeni
Rankless by CCL
2026